Visakhapatnam: Eisai Pharma, a noted human health care pharmaceutical company, announced its plans to establish a new global capability center (GCC) i.

Eisai Pharma is set to establish a new Global Capability Center (GCC) in Visakhapatnam, aiming to boost its digital transformation efforts in India.

Eisai Pharma, a leading human health care (hhc) pharmaceutical company with a global footprint, announced on Wednesday its plan to establish a new Global Capability Center (GCC) in Visakhapatnam ...

Eisai has scaled down its sales expectations for Alzheimer's disease drug Leqembi after sluggish sales growth in the first half of the current fiscal year.

Eisai and Biogen have completed their rolling biologics license application in the US for a subcutaneous formulation of Alzheimer's disease therapy Leqembi previously delayed by the FDA on ...

SAN FRANCISCO--An experimental Alzheimer’s disease drug from Eisai and Biogen slowed cognitive decline in a closely watched trial but may carry a risk of dangerous side effects for certain ...

Review the current Eisai Co Ltd (4523:XTKS) dividend yield and history to decide if 4523 is the best investment for you.

TOKYO, July 8, 2025 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced that it has been selected for the highest rating of “Supplier Engagement Leader” in ...

Eisai Pharma, a noted human health care pharmaceutical company with a global presence, announced its plans to establish a new Global Capability Center (GCC) in Visakhapatnam.

Find out all the key statistics for Eisai Co., Ltd. (ESAIY), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.

Dad’s funeral was held on Saturday, July 5, with our cousin, the Rev. Tony Alstott, officiating. Visitation was held at the Market Street Chapel of Naville & Seabrook Funeral Home followed immediately ...